Back to Search
GERALD I SHULMAN MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1235112319Individual
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
027683(CT)
Research & Publications (20)
Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition.
PMID 19648649·J Biol Chem·2009
7-preclinical
Mitochondrial dysfunction contributes to impaired insulin secretion in INS-1 cells with dominant-negative mutations of HNF-1alpha and in HNF-1alpha-deficient islets.
PMID 19376774·J Biol Chem·2009
7-preclinical
Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy.
PMID 15304632·Physiology (Bethesda)·2004
6-review
Assessment of in vivo mitochondrial metabolism by magnetic resonance spectroscopy.
PMID 19426879·Methods Enzymol·2009
7-preclinical
Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues.
PMID 18952837·Diabetes·2009
7-preclinical
STAT3 inhibition of gluconeogenesis is downregulated by SirT1.
PMID 19295512·Nat Cell Biol·2009
7-preclinical
Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression.
PMID 19366863·Diabetes·2009
7-preclinical
Phosphoenolpyruvate cycling via mitochondrial phosphoenolpyruvate carboxykinase links anaplerosis and mitochondrial GTP with insulin secretion.
PMID 19635791·J Biol Chem·2009
7-preclinical
Paradoxical coupling of triglyceride synthesis and fatty acid oxidation in skeletal muscle overexpressing DGAT1.
PMID 19675136·Diabetes·2009
7-preclinical
Interaction of stimulus-driven reorienting and expectation in ventral and dorsal frontoparietal and basal ganglia-cortical networks.
PMID 19357267·J Neurosci·2009
4-observational
AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency.
PMID 19136964·Nat Med·2009
7-preclinical
The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance.
PMID 19254570·Cell Metab·2009
7-preclinical
Adipose overexpression of desnutrin promotes fatty acid use and attenuates diet-induced obesity.
PMID 19136649·Diabetes·2009
7-preclinical
SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats.
PMID 19549853·Proc Natl Acad Sci U S A·2009
7-preclinical
Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.
PMID 19587243·Proc Natl Acad Sci U S A·2009
7-preclinical
Increased energy expenditure and insulin sensitivity in the high bone mass DeltaFosB transgenic mice.
PMID 18772235·Endocrinology·2009
7-preclinical
Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans.
PMID 19458062·Am J Physiol Endocrinol Metab·2009
3-trial
Dual role of proapoptotic BAD in insulin secretion and beta cell survival.
PMID 18223655·Nat Med·2008
7-preclinical
A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and mice.
PMID 18232732·PLoS Med·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 789 HOWARD AVE, DANA BUILDING - 3RD FLOOR
NEW HAVEN, CT 06519 - Phone
- (203) 737-1932
Quick Facts
- NPI
- 1235112319
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile